Federal Court Reinstates In-Person Requirement for Abortion Drug After FDA Admits Deficient Research

Posted 2 hours ago by

Must Read Alaska

In 2023, the U.S. Food and Drug Administration allowed the abortion drug mifepristone to be prescribed online and dispensed through the mail. Today, May 1, 2026, the U.S. Court of Appeals for the Fifth Circuit reinstated the in-person prescription requirement at least until the FDA finishes research regarding the drug’s safety. The decision aligns with [] The post Federal Court Reinstates In-Person Requirement for Abortion Drug After FDA Admits Deficient Research appeared first on Must Read Alaska.